References
- Enzinger F M, Weiss S W. Rhabdomyosarcoma. Soft Tissue Tumors. CV Mosby Company, St Louis, Washington, DC, Toronto 1988; 448–488
- Erlandson R A. The ultrastructural distinction between rhabdomyosarcoma and other undifferentiated “sarcomas.”?. Ultrastruct Pathol. 1987; 11: 83–101
- Seidal T, Kindblom L G, Angervall L. Alveolar and poorly differentiated rhabdomyosarcoma. A clinicopathologic, light-microscopic, ultrastructural and immunohistochemical analysis. APMIS. 1988; 96: 825–838
- Erlandson R A. Cytoskeletal proteins including myofilaments in human tumors. Ultrastruct Pathol. 1989; 13: 155–186
- Hsu S M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981; 29: 577–580
- Scopsi L, Migliari M, Vergani B, Lombardi L. The use of fixed-frozen tissue in routine ultrastructural evaluation and immunogold labeling. Ultrastruct Pathol. 1992; 16: 351–362
- Loesser K E, Doane K J, Wilson F J, Malamed S. Improved immunoelectron microscopic method for localizing cytoskeletal proteins in Lowicryl K4M embedded tissues. J Histochem Cytochem. 1986; 34: 1477–1485
- La Valle Bundtzen J, Norback D H. The ultrastructure of poorly differentiated rhabdomyosarcomas. A case report and literature review. Hum Pathol. 1982; 13: 301–313
- Seidal T, Kindblom L G, Angervall L. Rhabdomyosarcoma in middle-aged and elderly individuals. APMIS. 1989; 97: 236–248
- Altmansberger M, Osborn M, Treuner J, Holscher A, Weber K, Schauer A. Diagnosis of human childhood rhabdomyosarcoma by antibodies to desmin, the structural protein of muscle specific intermediate filaments. Virchows Arch [B] 1982; 39: 203–215
- Altmansberger M, Weber K, Droste R, Osborn M. Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am J Pathol. 1985; 118: 85–95
- Enzinger F M, Lattes R, Torloni H. Histological typing of soft tissue tumors. Paper presented at the International Histological Typing of Soft Tissue Tumors. World Health Organization, Geneva 1969, No. 3
- Gard D L, Lazarides E. The synthesis and distribution of desmin and vimentin during myogenesis in vitro. Cell. 1980; 19: 263–274
- Miettinen M, Letho V P, Badley R A, Virtanen I. Alveolar rhabdomyosarcoma. Demonstration of the muscle type of intermediate filament protein, desmin, as a diagnostic aid. Am J Pathol. 1982; 108: 246–251
- Schmid E, Osborn M, Rungger-Brandle E, Baggiani G, Weber K, Franke W W. Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. Exp Cell Res. 1982; 137: 329–340
- Shimada H, Newton W A, Soule E H, Beltangady M S, Maurer H M. Pathology of fatal rhabdomyosarcoma. Report from intergroup rhabdomyosarcoma study (IRS-I and IRS-II). Cancer. 1987; 59: 459–465
- Dickman P S, Triche T J. Extraosseus Ewing's sarcoma versus primitive rhabdomyosarcoma. Diagnostic criteria and clinical correlation. Hum Pathol. 1986; 17: 881–883
- Molenaar W M, Oosterhuis J W, Oosterhuis A M, Ramaekers F CS. Mesenchymal and muscle specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcoma. Hum Pathol. 1985; 16: 838–843